Carlos Nueno has sold TDOC and made no open-market buys since Dec 2025

Carlos Nueno is President, International at Teladoc Health, Inc. (NYSE: TDOC), where he oversees the strategic direction, operations, and client management for the company’s global footprint.( A seasoned corporate insider, he has led Teladoc Health’s international business since the 2018 acquisition of Advance Medical, and has recently executed multiple equity transactions in Teladoc Health stock in his capacity as Pres, International.( Prior to joining Teladoc Health, Nueno co-founded and served as CEO of Advance Medical, a leading provider of global health services to corporations and insurance companies, growing the firm to more than 900 employees across North America, Europe, and Asia before its acquisition.(

Nueno brings more than 20 years of global healthcare and health technology leadership experience, having previously worked as a consultant at Gemini Consulting early in his career.( He holds an industrial and mechanical engineering degree from the Polytechnic University of Catalonia (UPC) in Barcelona and an MBA from IESE Business School.( Born in Boston in 1973 and now a prominent figure in digital health, he frequently represents Teladoc Health at international industry events and forums focused on virtual care and global health innovation.(

Written by Perplexity from public sources.